November 6, 2008 — Human papillomavirus (HPV) infection has recently been established as an important risk factor for oropharyngeal cancers. Using a noninvasive oral rinse, researchers have now ...

Data shows Versamune® HPV may effectively treat HPV16-associated cancers; Phase 3 trial in head and neck cancer starts Q1 2025. PDS Biotechnology Corporation announced promising data for its lead ...

PRINCETON, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...

From 2006 to 2023, the adjusted proportion of vaccinated women in the U.S. who were positive for the high-risk HPV-16 and HPV-18 types dropped 98.4%. The proportion of unvaccinated adolescent girls ...

• In July 2022, Voltron Therapeutics, Inc., announced that data from the previously announced Study ‘098 demonstrated clear Proof-of Concept for VTX-067 in the treatment of HPV-related cancers. This ...

PRINCETON, N.J., Oct. 23, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted ...

Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab alone in patients with recurrent or metastatic HPV16-positive cervical and anogenital ...

While most human papillomavirus (HPV) infection clears on its own, persistent HPV infection can cause genital warts and anal, penile and oropharyngeal cancers in men. Dr. Sadeep Shrestha, associate ...

Multi-feature next-generation liquid biopsy for diagnosis and prognosis in HPV-associated head and neck cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...

Although human papillomavirus (HPV) was detected in 40% of pregnant women, only 7.2% of neonates tested positive for HPV. “Although HPV was detected in placentas, it remains difficult to differentiate ...